Literature DB >> 2156260

Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

G M Ramsay1, G Moscovici, C Moscovici, J M Bishop.   

Abstract

Damage to the protooncogene MYC has been implicated in the genesis of diverse human tumors, but the tumorigenic potential of the isolated gene has been disputed. Here we report the use of a retroviral vector to test the potency of human MYC for neoplastic transformation in avian cells. We found that sustained and abundant expression of MYC can transform both embryonic fibroblasts and hematopoietic cells and elicit granulocytic leukemias in chickens. Transformation by MYC is accompanied by changes in diverse aspects of cellular phenotype, including morphology, ability to grow in suspension, rate of proliferation, the structure of the cytoskeleton, and the composition of the extracellular matrix. Nevertheless, the biological potency of MYC is inherently constrained when compared to that of the retroviral oncogene v-myc. Our findings enlarge on previous descriptions of neoplastic transformation by MYC and sustain the view that ungoverned expression of the gene can contribute to the genesis of human tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156260      PMCID: PMC53634          DOI: 10.1073/pnas.87.6.2102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation.

Authors:  H Beug; A von Kirchbach; G Döderlein; J F Conscience; T Graf
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

2.  Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29.

Authors:  D Sheiness; L Fanshier; J M Bishop
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

3.  Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture.

Authors:  E Mougneau; L Lemieux; M Rassoulzadegan; F Cuzin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

4.  New procedure for DNA transfection with polycation and dimethyl sulfoxide.

Authors:  S Kawai; M Nishizawa
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

5.  Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by chicken c-myb gene.

Authors:  K H Klempnauer; G Symonds; G I Evan; J M Bishop
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

6.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

7.  Avian proto-myc genes promoted by defective or nondefective retroviruses are single-hit transforming genes in primary cells.

Authors:  R P Zhou; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts.

Authors:  H Iba; T Takeya; F R Cross; T Hanafusa; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic.

Authors:  S Palmieri; P Kahn; T Graf
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  10 in total

1.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  The c-myc proto-oncogene regulates cardiac development in transgenic mice.

Authors:  T Jackson; M F Allard; C M Sreenan; L K Doss; S P Bishop; J L Swain
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells.

Authors:  R Li; R P Zhou; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.

Authors:  J Laurence; S M Astrin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.

Authors:  Achuth Padmanabhan; Xiang Li; Charles J Bieberich
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

8.  Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development.

Authors:  T Jackson; M F Allard; C M Sreenan; L K Doss; S P Bishop; J L Swain
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

9.  Network-Based Pharmacological Study on the Mechanism of Action of Buxue Liqi Huatan Decoction in the Treatment of Lung Cancer.

Authors:  Huabing Wei; Lihuang Zhou; Xiaojing Zhao; Feng Xie
Journal:  Comput Intell Neurosci       Date:  2022-08-19

10.  Constitutively active TrkB confers an aggressive transformed phenotype to a neural crest-derived cell line.

Authors:  J Dewitt; V Ochoa; J Urschitz; M Elston; S Moisyadi; R Nishi
Journal:  Oncogene       Date:  2013-03-04       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.